The next confirmation statement is due 14 Apr 2026. Active PSCs are listed on the public register.
Public company register page
DAWN BIOPHARMA LTD
Companies House number 14824299. This page summarizes the public-register confirmation statement deadline and due date for this company, alongside officers, PSCs, and recent filing history from Companies House.
2 active officers currently exposed on the public register.
1 active people with significant control currently exposed on the public register.
Total exemption full accounts made up to 2025-12-31 on 25 Mar 2026
Entity Watch briefing
DAWN BIOPHARMA LTD is currently listed as active and recorded as a ltd on the public register. The next confirmation statement is due 14 Apr 2026, which is the next obvious register deadline to watch. The freshest filing signal is total exemption full accounts made up to 2025-12-31 on 25 Mar 2026.
The next confirmation statement is due 14 Apr 2026, 2 days from today, so this is the next obvious compliance checkpoint for the company record.
Only one active PSC is currently exposed on the public register, which points to a concentrated control profile rather than a broad shareholder picture.
The latest filing is accounts-related: Total exemption full accounts made up to 2025-12-31 on 25 Mar 2026. That is more useful as a financial-reporting freshness signal than a control or officer-change signal.
This company has been on the public register since 24 Apr 2023 - roughly 2 years - which helps separate an established record from a newly formed one.
Quick answers about DAWN BIOPHARMA LTD
These answer the exact register questions people usually search first.
When is the next confirmation statement due for DAWN BIOPHARMA LTD?
The next confirmation statement due date currently shown on the public record is 14 Apr 2026.
Is DAWN BIOPHARMA LTD overdue?
Entity Watch currently reads this company as confirmation statement due soon. The next confirmation statement is due 14 Apr 2026. Active PSCs are listed on the public register.
Who are the active officers of DAWN BIOPHARMA LTD?
The public register currently shows 2 active officers: RAJKOMAR, Iyona-Anishta, Mrs., RATAN, Anuv.
Who are the PSCs of DAWN BIOPHARMA LTD?
The public register currently shows 1 active PSC: Kkr & Co. Inc..
What was the latest filing for DAWN BIOPHARMA LTD?
The latest filing currently shown is Total exemption full accounts made up to 2025-12-31 dated 25 Mar 2026 with filing code AA.
What changed recently at DAWN BIOPHARMA LTD?
DAWN BIOPHARMA LTD is currently listed as active and recorded as a ltd on the public register. The next confirmation statement is due 14 Apr 2026, which is the next obvious register deadline to watch. The freshest filing signal is total exemption full accounts made up to 2025-12-31 on 25 Mar 2026.
Company facts
Duo, Level 6, 280 Bishopsgate, London, EC2M 4RB, United Kingdom
24 Apr 2023
14 Apr 2026
31 Mar 2026
Officers
Current public-register officers for this company.
Director
Appointed 31 May 2023
Director
Appointed 14 Jan 2025
Recent filing history
Latest filing events exposed through the Companies House filing-history API.
Total exemption full accounts made up to 2025-12-3125 Mar 2026
Form AA. Filed on 2026-03-25.
Statement of capital following an allotment of shares on 2025-12-1011 Dec 2025
Form SH01. Filed on 2025-12-11. Capital recorded: USD 13.76.
Total exemption full accounts made up to 2024-12-3130 Sept 2025
Form AA. Filed on 2025-09-30.
Statement of capital following an allotment of shares on 2025-04-1614 May 2025
Form SH01. Filed on 2025-05-14. Capital recorded: USD 9.29.
Confirmation statement made on 2025-03-31 with updates1 May 2025
Form CS01. Filed on 2025-05-01.
Change of details for Kkr & Co. Inc. as a person with significant control on 2025-04-099 Apr 2025
Form PSC05. Filed on 2025-04-09.
Change of details for Kkr & Co. Inc. as a person with significant control on 2025-03-2525 Mar 2025
Form PSC05. Filed on 2025-03-25.
Certificate of change of name17 Feb 2025
Form CERTNM. Filed on 2025-02-17.
Statement of capital following an allotment of shares on 2025-01-313 Feb 2025
Form SH01. Filed on 2025-02-03. Capital recorded: USD 5.49.
Appointment of Anuv Ratan as a director on 2025-01-1416 Jan 2025
Form AP01. Filed on 2025-01-16.
Total exemption full accounts made up to 2023-12-319 Sept 2024
Form AA. Filed on 2024-09-09.
Statement of capital following an allotment of shares on 2024-08-0623 Aug 2024
Form SH01. Filed on 2024-08-23. Capital recorded: USD 4.06.